squamous carcinoma of the anal canal
Showing 1 - 25 of >10,000
Anal Canal Cancer Stage III, Anal Squamous Cell Carcinoma, Anal Canal Cancer Trial in Guangzhou (PD-1 inhibitor, concurrent
Recruiting
- Anal Canal Cancer Stage III
- +3 more
- PD-1 inhibitor
- concurrent chemoradiotherapy
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital of Sun Yat-sen University
May 10, 2022
Anal Cancer Squamous Cell Trial in São Paulo (prebiotics in combination with probiotics)
Recruiting
- Anal Cancer Squamous Cell
- prebiotics in combination with probiotics
-
São Paulo, SP, BrazilAC Camargo Cancer Center
Jan 13, 2023
Squamous Cell Carcinoma of the Anal Canal Trial in Spain (Atezolizumab plus Tiraglolumab)
Not yet recruiting
- Squamous Cell Carcinoma of the Anal Canal
- Atezolizumab plus Tiraglolumab
-
Palma De Mallorca, Baleares, Spain
- +14 more
Dec 13, 2022
Tumor Recurrence After Abdominal-perineal Amputation in Squamous
Active, not recruiting
- Squamous Cell Carcinoma of the Anal Canal
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Jun 29, 2022
Response in Squamous Cell Carcinoma of Anal Canal
Active, not recruiting
- Squamous Cell Carcinoma
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Dec 31, 2021
Anal Canal Cancer, Anal Squamous Cell Carcinoma, Anal Cancer Trial in Guangzhou (Toripalimab)
Recruiting
- Anal Canal Cancer
- +5 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 19, 2021
Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Squamous Cell Carcinoma Trial in Philadelphia (Capecitabine,
Active, not recruiting
- Anal Basaloid Carcinoma
- +6 more
- Capecitabine
- +6 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jan 3, 2023
Anal Canal Squamous Cell Carcinoma Trial in Seoul (BI 754091, BI 836880)
Withdrawn
- Anal Canal Squamous Cell Carcinoma
- BI 754091
- BI 836880
-
Seoul, Korea, Republic ofAsan Medical Center
Nov 12, 2021
AIDS-Related Anal Carcinoma, Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma Trial in United States (drug, radiation,
Recruiting
- AIDS-Related Anal Carcinoma
- +22 more
- Capecitabine
- +4 more
-
San Francisco, California
- +8 more
Jan 27, 2023
Anal Canal Carcinoma Trial in France (Docetaxel, Cisplatin and 5-Fluorouracil)
Completed
- Anal Canal Carcinoma
- Docetaxel, Cisplatin and 5-Fluorouracil
-
Besançon, France
- +15 more
May 10, 2022
Squamous Cell Carcinoma of the Head and Neck, Anal Canal Cancer, Cervical Cancer Trial in France (biological, procedure, other,
Recruiting
- Squamous Cell Carcinoma of the Head and Neck
- +2 more
- Blood sample collection
- +4 more
-
Besançon, France
- +4 more
Nov 17, 2022
Research in Patients With Squamous Cell Anal Carcinoma
Withdrawn
- Anal Canal Cancer
- Additional biological samples
-
Besançon, France
- +1 more
Jul 26, 2021
Squamous Cell Cancer
Recruiting
- Squamous Carcinoma
- +5 more
-
Umeå, SwedenUmeå University
Sep 28, 2021
Squamous Cell Cancers Receiving Systemic Therapy
Active, not recruiting
- Cancer
- +4 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 11, 2021
Squamous Cell Carcinoma of Anal Canal Trial in Worldwide (Retifanlimab)
Completed
- Squamous Cell Carcinoma of Anal Canal
-
Duarte, California
- +46 more
Jan 11, 2022
Anal Squamous Cell Carcinoma Trial in New York (Artificial Intelligence Guided Daily Radiotherapy Treatment Planning and
Recruiting
- Anal Squamous Cell Carcinoma
- Artificial Intelligence Guided Daily Radiotherapy Treatment Planning and Delivery
- +3 more
-
New York, New YorkColumbia University Irving Medical Center
Apr 27, 2023
Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma
Recruiting
- Anal Cancer
- Anal Squamous Intraepithelial Neoplasia
-
London, United KingdomImperial College London- Chelsea and Westminster NHS Foundation
Apr 19, 2023
COrSIcA: Disease Measurement
Not yet recruiting
- Anal Intraepithelial Neoplasia
- +2 more
- Physical examination
- (no location specified)
May 4, 2023
Stage IV Esophageal Adenocarcinoma, Stage IV Esophageal Squamous Cell Carcinoma, Stage IV Gastric Cancer Trial in San Francisco
Recruiting
- Stage IV Esophageal Adenocarcinoma
- +43 more
- Radiation Therapy (RT)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 29, 2022
ANAL PRECANCEROUS LESIONS IN HIGH-RISK PATIENTS.
Recruiting
- AIN3
- +2 more
- Detection of anal HSIL in a routine colonoscopy.
-
Gondomar, Porto, PortugalFernando Pessoa Teaching Hospital
Dec 9, 2022
A Global Record of Anal Squamous Cell Carcinoma With and Without
Not yet recruiting
- Anal Squamous Cell Carcinoma
- HIV Infections
- (no location specified)
Nov 28, 2022
Anal High Grade Squamous Intraepithelial Lesion, Anal Precancerous Condition, AIN 2/3 Trial in San Francisco, Chicago, New York
Not yet recruiting
- Anal High Grade Squamous Intraepithelial Lesion
- +5 more
- Artesunate
- Placebo
-
San Francisco, California
- +2 more
Nov 7, 2022
Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)
Recruiting
- Ovarian Cancer
- +10 more
-
West Hollywood, California
- +27 more
Jun 27, 2022
Squamous Cell Anal Carcinoma, Metastatic Squamous Cell Carcinoma Trial in Besançon, Lyon, Montbeliard (Sample collection)
Recruiting
- Squamous Cell Anal Carcinoma
- Metastatic Squamous Cell Carcinoma
- Sample collection
-
Besançon, France
- +2 more
Mar 10, 2022
Anal Cancer Risk In Women
Recruiting
- Anal Cancer
- +4 more
- Dual Pathology
-
London, United Kingdom
- +1 more
Apr 19, 2023